1-6 of 6
Kuolung Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 Study in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Receiving Blinatumomab Treatment

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, Rupert Handgretinger, Tanya M. Trippett, Carmelo Rizzari, Christian M. Zwaan, Deepa Bhojwani, Steven G. Dubois, MD, Peter Bader, Arndt Borkhardt, Maureen O'Brien, Susan R. Rheingold, MD, Todd Michael Cooper, Kuolung Hu, Noemi Mergen, Anja Fischer, Min Zhu, Youssef Hijazi, James Whitlock, Lia Gore
Journal: Blood
Blood (2014) 124 (21): 2292.
https://doi.org/10.1182/blood.V124.21.2292.2292
Published: 2014
Journal Articles

Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Lia Gore, Franco Locatelli, Gerhard Zugmaier, Christian M. Zwaan, Deepa Bhojwani, Rupert Handgretinger, Peter Bader, Maureen M. O'Brien, Tanya M. Trippett, Benoît Brethon, Carmelo Rizzari, Steven G. DuBois, Paul Gerhardt Schlegel, Phillip Barnette, Chiara Messina, Kuolung Hu, Noemi Mergen, Anja Fischer, James Whitlock, Arend von Stackelberg
Journal: Blood
Blood (2014) 124 (21): 3703.
https://doi.org/10.1182/blood.V124.21.3703.3703
Published: 2014
Journal Articles

Treatment with the Thrombopoietin (TPO)-Receptor Agonist Romiplostim in Thrombocytopenic Patients (Pts) with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndrome (MDS): Results of a Randomized, Double-Blind, Placebo(PBO)-Controlled Study

Aristoteles Giagounidis, MD, Ghulam J. Mufti, MD, Hagop M. Kantarjian, Pierre Fenaux, MD, PhD, Mikkael A. Sekeres, MD, MS, Jeffrey Szer, MBBS, FRACP, Andrea Kuendgen, MD, Uwe Platzbecker, MD, Gianluca Gaidano, Wieslaw Jedrzejczak, Kuolung Hu, Allen S. Yang, MD, PhD, Susie Jun
Journal: Blood
Blood (2011) 118 (21): 117.
https://doi.org/10.1182/blood.V118.21.117.117
Published: 2011
Journal Articles

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

Clinical Trials & Observations
Hagop M. Kantarjian, Francis J. Giles, Peter L. Greenberg, Ron L. Paquette, Eunice S. Wang, Janice L. Gabrilove, Guillermo Garcia-Manero, Kuolung Hu, Janet L. Franklin, Dietmar P. Berger
Journal: Blood
Blood (2010) 116 (17): 3163–3170.
https://doi.org/10.1182/blood-2010-03-274753
Published: 2010
Journal Articles

Effect of Romiplostim in Patients (pts) with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Azacytidine

Hagop Kantarjian, MD, Frank Giles, MD, Peter Greenberg, MD, Ronald Paquette, MD, Eunice Wang, MD, Janice Gabrilove, MD, Guillermo Garcia-Manero, MD, Julie Gray, Kuolung Hu, PhD, Janet Franklin, MD, MPH
Journal: Blood
Blood (2008) 112 (11): 224.
https://doi.org/10.1182/blood.V112.11.224.224
Published: 2008
Journal Articles

Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients (pts) with Low-Risk Myelodysplastic Syndrome (MDS): Update Including Extended Treatment.

Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela Becker, Adam Boruchov, David Bowen, Richard Larson, Roger Lyons, Petra Muus, Jamile Shammo, Michael Ehrman, Kuolung Hu, Janet Nichol
Journal: Blood
Blood (2007) 110 (11): 250.
https://doi.org/10.1182/blood.V110.11.250.250
Published: 2007